GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 3.647
AS - Asia 1.965
EU - Europa 999
SA - Sud America 344
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 46
OC - Oceania 16
Totale 7.152
Nazione #
US - Stati Uniti d'America 3.510
SG - Singapore 794
IT - Italia 411
CN - Cina 313
BR - Brasile 267
VN - Vietnam 252
HK - Hong Kong 176
DE - Germania 160
BD - Bangladesh 89
GB - Regno Unito 77
IN - India 70
ID - Indonesia 65
JP - Giappone 65
CA - Canada 63
FR - Francia 49
MX - Messico 44
FI - Finlandia 43
NL - Olanda 43
PL - Polonia 42
RU - Federazione Russa 39
AR - Argentina 36
TR - Turchia 21
SE - Svezia 19
ES - Italia 18
ZA - Sudafrica 17
AU - Australia 16
IQ - Iraq 16
AT - Austria 15
AE - Emirati Arabi Uniti 12
CO - Colombia 12
UA - Ucraina 12
PK - Pakistan 11
MY - Malesia 10
CR - Costa Rica 9
EC - Ecuador 9
SA - Arabia Saudita 9
PH - Filippine 8
RO - Romania 8
CH - Svizzera 7
IE - Irlanda 7
LT - Lituania 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EG - Egitto 6
TH - Thailandia 6
VE - Venezuela 6
DK - Danimarca 5
GR - Grecia 5
JM - Giamaica 5
KR - Corea 5
BE - Belgio 4
HU - Ungheria 4
IL - Israele 4
NG - Nigeria 4
UY - Uruguay 4
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GD - Grenada 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 7.005
Città #
Singapore 497
Ashburn 461
San Jose 322
Council Bluffs 188
Santa Clara 182
Hong Kong 171
Chandler 127
Dallas 121
New York 100
Beijing 99
Los Angeles 92
Ho Chi Minh City 87
Munich 85
Milan 67
Tokyo 61
Hanoi 60
Jakarta 53
Fairfield 45
Warsaw 41
Atlanta 39
Lauterbourg 36
Shanghai 35
São Paulo 34
Ferrara 32
Bologna 31
Rome 31
Toronto 31
Houston 30
Mexico City 28
Chicago 27
San Francisco 24
Addison 23
London 23
Denver 22
Bremen 21
Buffalo 21
Chennai 21
Princeton 21
Phoenix 20
Helsinki 18
Orem 18
Hefei 17
The Dalles 17
Seattle 15
Brooklyn 14
Cambridge 14
Turku 14
Amsterdam 12
Frankfurt am Main 12
Manchester 12
Montreal 12
Wilmington 12
Modena 11
San Diego 11
Boston 10
Stockholm 10
Da Nang 9
Haiphong 9
Lappeenranta 9
Naples 9
New Delhi 9
Rio de Janeiro 9
Sydney 9
Woodbridge 9
Falkenstein 8
Florence 8
Kuala Lumpur 8
Moscow 8
Poplar 8
Salt Lake City 8
San José 8
Ann Arbor 7
Boardman 7
Casalecchio Di Reno 7
Charlotte 7
Hải Dương 7
Mumbai 7
Portland 7
Ankara 6
Baghdad 6
Newark 6
Ottawa 6
Washington 6
Brasília 5
Buenos Aires 5
Columbus 5
Guarulhos 5
Hillsboro 5
Johannesburg 5
Miami 5
Nuremberg 5
Paris 5
Thái Nguyên 5
Turin 5
Vienna 5
Assago 4
Bangkok 4
Barnet 4
Brno 4
Bến Tre 4
Totale 3.925
Nome #
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 1.087
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 219
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 215
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 201
A tool to predict survival in stage IV entero-pancreatic NEN 200
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 197
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 186
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 183
Functional hypothalamic and drug-induced amenorrhea: an overview 179
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 172
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 171
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 166
Acromegaly in the elderly patients 164
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 162
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 157
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 156
Craniopharyngioma and Eating Disorders 153
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 151
Bone health in adolescence 147
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 147
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 144
Long-term low-dose tolvaptan efficacy and safety in SIADH 144
Iperprolattinemia: vecchie e nuove insidie diagnostiche 144
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 140
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 139
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 135
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 134
Hypeprolactinemia: still an insidious diagnosis 128
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 128
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 125
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 120
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 119
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 113
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 109
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 99
I livelli di colesterolo LDL sono associati alla secrezione insulinica 98
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 95
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 93
L’acromegalia nell’anziano 91
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 86
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 82
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 79
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 69
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) [Neuroendocrine Neoplasms prognostic markers] 65
Acromegalia: differenze di sesso e genere [Sex and gender differences in acromegaly] 60
Totale 7.152
Categoria #
all - tutte 35.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 899
Totale 36.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 0 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/20251.264 43 50 96 52 138 138 60 54 217 118 162 136
2025/20263.636 348 131 319 418 554 226 408 229 298 407 177 121
2026/20271.334 761 461 112 0 0 0 0 0 0 0 0 0
Totale 7.152